Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Payables (2017 - 2025)

Catheter Precision (VTAK) has disclosed Payables for 9 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Payables rose 12.75% to $1.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.1 million, a 12.75% increase, with the full-year FY2024 number at $407000.0, down 37.19% from a year prior.
  • Payables was $1.1 million for Q3 2025 at Catheter Precision, down from $2.5 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $14.3 million in Q3 2023 to a low of $92000.0 in Q4 2022.
  • A 5-year average of $2.5 million and a median of $972500.0 in 2021 define the central range for Payables.
  • Peak YoY movement for Payables: soared 3018.91% in 2023, then tumbled 94.21% in 2024.
  • Catheter Precision's Payables stood at $988000.0 in 2021, then plummeted by 90.69% to $92000.0 in 2022, then surged by 604.35% to $648000.0 in 2023, then tumbled by 37.19% to $407000.0 in 2024, then skyrocketed by 165.11% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Payables are $1.1 million (Q3 2025), $2.5 million (Q2 2025), and $2.2 million (Q1 2025).